11/21
07:11 am
nvs
Velocity targets Latin America expansion with the appointment of Renata Berardocco as LATAM Managing Director [Yahoo! Finance]
Low
Report
Velocity targets Latin America expansion with the appointment of Renata Berardocco as LATAM Managing Director [Yahoo! Finance]
11/21
05:21 am
nvs
Swiss pharma giant Novartis says 30 pipeline drugs with ‘significant potential' will drive long-term growth [Fortune]
Low
Report
Swiss pharma giant Novartis says 30 pipeline drugs with ‘significant potential' will drive long-term growth [Fortune]
11/20
03:34 pm
nvs
BerGenBio Appoints Olav Hellebø as CEO [Yahoo! Finance]
Low
Report
BerGenBio Appoints Olav Hellebø as CEO [Yahoo! Finance]
11/20
09:08 am
nvs
Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies [Yahoo! Finance]
Low
Report
Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies [Yahoo! Finance]
11/20
06:12 am
nvs
NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board [Yahoo! Finance]
Low
Report
NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board [Yahoo! Finance]
11/19
12:46 pm
nvs
Novartis AG (NYSE: NVS) had its "hold" rating re-affirmed by analysts at Erste Group Bank AG.
Low
Report
Novartis AG (NYSE: NVS) had its "hold" rating re-affirmed by analysts at Erste Group Bank AG.
11/19
11:31 am
nvs
Dry Eye Syndrome Treatment (Evaporative, Aqueous Deficient) Market Trends Analysis Report 2024-2030: New Product Launches, Strategic Initiatives by Key Players, and Innovations Bolster Growth [Yahoo! Finance]
Low
Report
Dry Eye Syndrome Treatment (Evaporative, Aqueous Deficient) Market Trends Analysis Report 2024-2030: New Product Launches, Strategic Initiatives by Key Players, and Innovations Bolster Growth [Yahoo! Finance]
11/19
08:08 am
nvs
Novartis ranks first in 2024 Access to Medicine Index [Yahoo! Finance]
Low
Report
Novartis ranks first in 2024 Access to Medicine Index [Yahoo! Finance]
11/19
06:10 am
nvs
BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA [Yahoo! Finance]
Low
Report
BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA [Yahoo! Finance]
11/18
11:38 am
nvs
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
11/18
09:13 am
nvs
C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital [Yahoo! Finance]
Low
Report
C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital [Yahoo! Finance]
11/18
08:12 am
nvs
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate [Yahoo! Finance]
Low
Report
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate [Yahoo! Finance]
11/18
08:00 am
nvs
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
Low
Report
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
11/18
07:28 am
nvs
CAR T-Cell Therapy Market to Surpass Valuation of USD 106.06 Billion by 2031 | SkyQuest Technology [Yahoo! Finance]
Low
Report
CAR T-Cell Therapy Market to Surpass Valuation of USD 106.06 Billion by 2031 | SkyQuest Technology [Yahoo! Finance]
11/18
05:03 am
nvs
Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors [Yahoo! Finance]
Low
Report
Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors [Yahoo! Finance]
11/16
04:45 pm
nvs
Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban [Yahoo! Finance]
Low
Report
Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban [Yahoo! Finance]
11/15
11:54 am
nvs
Here's Why Novartis (NVS) is a Strong Value Stock [Yahoo! Finance]
Low
Report
Here's Why Novartis (NVS) is a Strong Value Stock [Yahoo! Finance]
11/15
11:13 am
nvs
MEDIA STATEMENT - Novartis Canada disappointed with outcome of pCPA negotiations for metastatic castration resistant prostate cancer treatment PLUVICTO™ [Globe and Mail, The (Toronto, Canada)]
Low
Report
MEDIA STATEMENT - Novartis Canada disappointed with outcome of pCPA negotiations for metastatic castration resistant prostate cancer treatment PLUVICTO™ [Globe and Mail, The (Toronto, Canada)]
11/15
11:11 am
nvs
MEDIA STATEMENT - Novartis Canada disappointed with outcome of pCPA negotiations for metastatic castration resistant prostate cancer treatment PLUVICTO™ [Yahoo! Finance]
Low
Report
MEDIA STATEMENT - Novartis Canada disappointed with outcome of pCPA negotiations for metastatic castration resistant prostate cancer treatment PLUVICTO™ [Yahoo! Finance]
11/13
01:17 pm
nvs
Leerink Partners Hires Bankers From Guggenheim, Gordon Dyal [Yahoo! Finance]
Low
Report
Leerink Partners Hires Bankers From Guggenheim, Gordon Dyal [Yahoo! Finance]
11/13
11:16 am
nvs
Novartis (NVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Low
Report
Novartis (NVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
11/13
11:16 am
nvs
Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS) [Yahoo! Finance]
Low
Report
Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS) [Yahoo! Finance]
11/12
11:36 am
nvs
Self Amplifying RNA Vaccines Patent Landscape and Forecast Report 2024-2032, Featuring Gentech, Novartis, Human Genome Sciences, Immatics Biotechnologies and Broad Institute [Yahoo! Finance]
Low
Report
Self Amplifying RNA Vaccines Patent Landscape and Forecast Report 2024-2032, Featuring Gentech, Novartis, Human Genome Sciences, Immatics Biotechnologies and Broad Institute [Yahoo! Finance]
11/12
06:55 am
nvs
Schrödinger Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Schrödinger Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/5
11:04 am
nvs
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]